Archives life-sciences+life-sciences

by in
Entry Author Date Location
Beer Out as Struggling Aegerion Shuffles Leadership Ranks 07/27/15 Boston
FDA OKs Cholesterol Fighter Praluent For More Patients Than Expected 07/24/15 New York
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
Ginkgo Bioworks Adds $45M to Expand Organism Engineering 07/23/15 Boston
“Boston’s Life Science Disruptors” to Share Their Stories on Sept. 30 07/23/15 Boston
Ra Pharma Gets $58.5M in Crossover Cash to Target Rare Blood Disease 07/23/15 Boston
RaNA CEO Renaud Turns To A Former Backer To Lead $55M Series B 07/23/15 Boston
With New Alzheimer’s Data, Biogen Refines Plans For Big Trial 07/22/15 Boston
In Biotech, Everyone’s Going Public. What’s Your Excuse? 07/22/15 National
East Coast Biotech Roundup: Celgene, Chiasma, Cerulean, & More 07/17/15 Boston
Orphan Drug Maker Chiasma Raises $101.8M in IPO 07/16/15 Boston
EyeGate CEO: Valeant Deal Helps Company Avoid Mistakes of Past 07/15/15 Boston
Celgene to Acquire San Diego’s Receptos for $7.2B in Cash 07/14/15 San Diego
FDA Grants Blueprint Go-Ahead for Kinase Inhibitor Trials 07/13/15 Boston
East Coast Biotech Roundup: Biogen, Epizyme, Armored CARS, & More 07/13/15 Boston
The Near Death, and Second Life, of Cerulean Pharma 07/13/15 Boston
EyeGate Deals Treatment Rights to Valeant to Pay for Clinical Trials 07/10/15 Boston
21st Century Cures Act Passes House, Now Must Navigate Senate 07/10/15 National
Biogen R&D Chief Doug Williams Leaves to Run New Cancer Startup 07/10/15 Boston
With PCSK9’s Origins In Mind, Sanofi Has UT Join Funding Program 07/09/15 Texas
Epizyme Extends Celgene Cancer Deal for $10M Upfront 07/09/15 Boston
Tackling Sickle Cell, Global Blood Therapeutics Joins IPO Queue 07/08/15 San Francisco
For Biotech Cowboys, It’s No Ride Into The Sunset 07/08/15 National
Chiasma Seeks $75 Million and FDA Approval for Acromegaly Orphan Drug 07/06/15 Boston
East Coast Biotech Roundup: Vertex, Biogen, Sarepta, Juno, & More 07/06/15 Boston
FDA Approves Vertex’s Two-Drug Combo For Cystic Fibrosis 07/02/15 Boston
Biogen Offers Up To $1 Billion for AGTC’s Ophthalmology Gene Therapy 07/02/15 Boston
XRpro Resurrects Icagen With Buy of Some Pfizer Ion Channel Assets 07/02/15 Boston
Doctors See Big Cybersecurity Risks, Compliance as Key for Hospitals 07/01/15 Boston
Amag Seeks New Chapter With $700M Cord Blood Registry Purchase 06/30/15 Boston
Page 2 of 99 « previous page · next page »